LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 7.77 | 84.90 | 716 | 411 | 1.7411 | 1.5517 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 9.47 | 84.90 | 717 | 447 | 1.6025 | 1.4347 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 9.47 | 84.90 | 763 | 447 | 1.7053 | 1.4986 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 11.18 | 84.90 | 706 | 492 | 1.4339 | 1.3054 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 11.18 | 84.90 | 828 | 492 | 1.6817 | 1.4550 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 12.88 | 84.90 | 1 | 531 | 0.0019 | -0.8135 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 12.88 | 84.90 | 818 | 531 | 1.5405 | 1.3549 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 12.88 | 84.90 | 1 | 531 | 0.0019 | -0.8135 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 12.88 | 84.90 | 871 | 531 | 1.6403 | 1.4115 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 14.58 | 84.90 | 57 | 663 | 0.0859 | -0.1257 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 14.58 | 84.90 | 769 | 663 | 1.1592 | 1.1021 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 14.58 | 84.90 | 1 | 663 | 0.0015 | -0.7763 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 14.58 | 84.90 | 891 | 663 | 1.3431 | 1.2091 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 16.29 | 84.90 | 92 | 766 | 0.1200 | 0.0256 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 16.29 | 84.90 | 880 | 766 | 1.1475 | 1.0886 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 16.29 | 84.90 | 1 | 766 | 0.0013 | -0.7531 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 16.29 | 84.90 | 889 | 766 | 1.1593 | 1.0953 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 17.99 | 84.90 | 138 | 898 | 0.1535 | 0.1534 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 17.99 | 84.90 | 873 | 898 | 0.9711 | 0.9829 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 17.99 | 84.90 | 1 | 898 | 0.0011 | -0.7287 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 17.99 | 84.90 | 830 | 898 | 0.9233 | 0.9537 | MN20160318_Q02 | G16 |